Breaking News Instant updates and real-time market news.

MGLN

Magellan Health

$71.36

6.31 (9.70%)

11:20
02/20/19
02/20
11:20
02/20/19
11:20

Magellan Health jumps 8% after Reuters says exploring sale

Magellan Health is exploring a sale of the company amid pressure from activist Starboard Value, Reuters reports, citing people familiar with the matter. Magellan is being advised by Goldman Sachs and is in the early stages of considering takeover interest, sources told Reuters. Shares of Magellan Health jumped 8%, or $5.11, to $70.13 following the report. Reference Link

MGLN Magellan Health
$71.36

6.31 (9.70%)

09/20/18
LEER
09/20/18
NO CHANGE
Target $250
LEER
Outperform
Cigna price target raised to $250 from $235 at Leerink
Leerink analyst Ana Gupte raised her price target on Outperform-rated Cigna (CI) to $250 from $235 following meetings with a panel of PBM and Specialty Rx specialists, which increased her bullishness on Cigna and Market Perform-rated Express Scripts (ESRX). In a research note to investors, Gupte says she also came away with raised confidence on the achiveability of the $4B annual drug cost savings from the Express Scripts switch by Anthem (ANTM) to IngenioRx in partnership with CVS (CVS). She adds that smaller independent PBMs still have niche opportunities with smaller regional third-party health plans, noting that Magellan Health (MGLN) is well positioned in this market, though loss of substantial business in Florida Seriously Mentally Ill is a headwind in Rx as well.
11/13/18
LEER
11/13/18
DOWNGRADE
Target $70
LEER
Market Perform
Magellan Health downgraded to Market Perform from Outperform at Leerink
Leerink analyst Ana Gupte downgraded Magellan Health to Market Perform and lowered her price target for the shares to $70 from $90. The analyst says the stock has had "enormous challenges" since her upgrade, including the loss of the flagship serious mental ill contract in Florida. She believes "carve-out challenges could keep contract wins pressured in other states." Further, Magellan's margins do not look likely to normalize until late 2019 and or even 2020, Gupte tells investors in a research note.
11/28/18
JEFF
11/28/18
NO CHANGE
Target $79
JEFF
Buy
Jefferies sees Magellan turning Virginia around after Srivastava ouster
Jefferies analyst David Styblo believes Magellan Health's termination of Sam Srivastava, the CEO of its Healthcare division, shouldn't be too surprising given the challenges that business has had this year, particularly in the Virginia Medicaid start-up. Magellan CEO Barry Smith will take over and have a more direct role in improving performance, including spending time on the Virginia contract, Styblo tells investors in a research note. The analyst views the Virginia contract as a large opportunity and a key to realizing "significant" earnings power over the next few years. Styblo estimates the contract has $2.30 of earnings per share power from 2018. He thinks Magellan "can turn Virginia around" and keeps a Buy rating on the shares with a $79 price target.
01/14/19
SPHN
01/14/19
INITIATION
Target $68
SPHN
Equal Weight
Magellan Health initiated with an Equal Weight at Stephens
Stephens analyst Scott Fidel initiated coverage of 11 Managed Care and Healthcare Facilities stocks, telling investors that overall he is constructive on managed care and selective on hospitals. He started Magellan Health with an Equal Weight rating and $68 price target, citing what he calls its "disappointing fundamental execution" in 2018. While the emergence of an activist investor will likely increase accountability and urgency, he would wait for some initial signs of improving business trends before getting more constructive, Fidel tells investors.

TODAY'S FREE FLY STORIES

CVCY

Central Valley Community

$21.49

0.88 (4.27%)

09:24
09/23/19
09/23
09:24
09/23/19
09:24
Downgrade
Central Valley Community rating change  »

Central Valley Community…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIVE

Five Below

$126.54

-1.89 (-1.47%)

09:23
09/23/19
09/23
09:23
09/23/19
09:23
Recommendations
Five Below analyst commentary  »

Five Below's Ten…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSY

Hershey

$154.15

0.73 (0.48%)

09:22
09/23/19
09/23
09:22
09/23/19
09:22
Hot Stocks
Hershey completes acquisition of ONE Brands for $397M »

The Hershey Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Healthcare

$124.35

-2.51 (-1.98%)

09:20
09/23/19
09/23
09:20
09/23/19
09:20
Hot Stocks
HCA Healthcare CHRO John Steele to retire, Jennifer Berres to succeed »

HCA Healthcare announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

REGN

Regeneron

$295.79

9.51 (3.32%)

, SNY

Sanofi

$46.50

1.61 (3.59%)

09:20
09/23/19
09/23
09:20
09/23/19
09:20
Upgrade
Regeneron, Sanofi, Roche rating change  »

Guggenheim upgrades…

REGN

Regeneron

$295.79

9.51 (3.32%)

SNY

Sanofi

$46.50

1.61 (3.59%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

  • 04

    Nov

SVMK

SurveyMonkey

$18.14

-0.16 (-0.87%)

09:20
09/23/19
09/23
09:20
09/23/19
09:20
Hot Stocks
SurveyMonkey achieves ISO recognition from the British Standards Institute »

SurveyMonkey announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$18.46

-0.29 (-1.55%)

09:18
09/23/19
09/23
09:18
09/23/19
09:18
Hot Stocks
HP Inc. partners with WWF on forest protection, restoration, management »

HP announced its next…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
09/23/19
09/23
09:18
09/23/19
09:18
Options
Overnight activity included 303 trades in SPX and 5 trades in VIX »

303 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSCO

Nesco Holdings

$6.75

-0.055 (-0.81%)

09:17
09/23/19
09/23
09:17
09/23/19
09:17
Hot Stocks
Nesco Holdings to acquire Truck Utilities for $42.2M »

Nesco Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNPQY

BNP Paribas

$0.00

(0.00%)

09:16
09/23/19
09/23
09:16
09/23/19
09:16
Hot Stocks
BNP Paribas becomes founding signatory of Principles for Responsible Banking »

BNP Paribas became one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$46.50

1.61 (3.59%)

, REGN

Regeneron

$295.79

9.51 (3.32%)

09:16
09/23/19
09/23
09:16
09/23/19
09:16
Upgrade
Sanofi, Regeneron rating change  »

Sanofi upgraded to Buy on…

SNY

Sanofi

$46.50

1.61 (3.59%)

REGN

Regeneron

$295.79

9.51 (3.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

HZN

Horizon Global

$3.89

-0.12 (-2.99%)

09:15
09/23/19
09/23
09:15
09/23/19
09:15
Hot Stocks
Horizon Global appoints Terrence Gohl as CEOHorizon Global »

Horizon Global announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TA

TravelCenters

$12.46

-0.72 (-5.46%)

09:15
09/23/19
09/23
09:15
09/23/19
09:15
Hot Stocks
TravelCenters signs franchise agreement with Biggs Petroleum »

TravelCenters has signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABEO

Abeona Therapeutics

$3.26

-0.005 (-0.15%)

09:15
09/23/19
09/23
09:15
09/23/19
09:15
Hot Stocks
Breaking Hot Stocks news story on Abeona Therapeutics »

Abeona Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

PUYI

Puyi

$6.72

0.12 (1.82%)

09:14
09/23/19
09/23
09:14
09/23/19
09:14
Hot Stocks
Puyi appoints Yong Ren as CEO »

Puyi announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXT

Textron

$50.91

-0.53 (-1.03%)

09:13
09/23/19
09/23
09:13
09/23/19
09:13
Hot Stocks
Textron says Cessna Citation Longitude receives FAA Type Certification »

Textron Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ACAD

Acadia

$40.81

-0.89 (-2.13%)

09:13
09/23/19
09/23
09:13
09/23/19
09:13
Hot Stocks
Acadia announces results from Phase 2 pimavanserin study »

Acadia announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

MATN

Mateon Therapeutics

$0.00

(0.00%)

09:13
09/23/19
09/23
09:13
09/23/19
09:13
Hot Stocks
Mateon Therapeutics granted Rare Pediatric Disease Designation for OT101 »

Mateon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$111.21

0.17 (0.15%)

09:11
09/23/19
09/23
09:11
09/23/19
09:11
Hot Stocks
Medtronic announces FDA approval of Evolut PRO+ TAVR System »

Medtronic announced U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

09:10
09/23/19
09/23
09:10
09/23/19
09:10
Conference/Events
Morgan Stanley to hold a conference »

Japan TMT/Consumer…

BLGO

BioLargo

$0.00

(0.00%)

09:10
09/23/19
09/23
09:10
09/23/19
09:10
Hot Stocks
BioLargo subsidiary Clyra Medical receives FDA 510(k) clearance »

BioLargo announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:09
09/23/19
09/23
09:09
09/23/19
09:09
Conference/Events
Oliver Wyman to hold a conferenc »

InsureTech Connect 2019…

CCS

Century Communities

$29.98

-0.32 (-1.06%)

, MDC

M.D.C. Holdings

$42.43

0.14 (0.33%)

09:08
09/23/19
09/23
09:08
09/23/19
09:08
Conference/Events
Evercore ISI to hold a field trip »

Homebuilding Trip travels…

CCS

Century Communities

$29.98

-0.32 (-1.06%)

MDC

M.D.C. Holdings

$42.43

0.14 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

ALTR

Altair

$34.08

-0.49 (-1.42%)

, F

Ford

$9.16

0.06 (0.66%)

09:08
09/23/19
09/23
09:08
09/23/19
09:08
Hot Stocks
Altair appoints Andrea Siudara as CIO »

Altair (ALTR) announced…

ALTR

Altair

$34.08

-0.49 (-1.42%)

F

Ford

$9.16

0.06 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 23

    Oct

  • 23

    Oct

SMTX

SMTC Corp.

$2.54

-0.42 (-14.19%)

09:08
09/23/19
09/23
09:08
09/23/19
09:08
Recommendations
SMTC Corp. analyst commentary  »

SMTC Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.